Tania Konry

Dr. Tania Konry


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Journal of Controlled Release
Verified
Journal Article
Closed access
PSPooja Sabhachandani
Pooja Sabhachandani
SSSaheli Sarkar
Saheli Sarkar
SMSeamus Mckenney
Seamus Mckenney
RDRavi Dashnamoorthy
Ravi Dashnamoorthy
AEAndrew M Evens
Andrew M Evens
TKTania Konry
Tania Konry

15 September 2017 in Microchimica Acta
Verified
Journal Article
Closed access
PDF file
PSPooja Sabhachandani
Pooja Sabhachandani
SSSaheli Sarkar
Saheli Sarkar
PZPaola C. Zucchi
Paola C. Zucchi
BWBetsy A. Whitfield
Betsy A. Whitfield
JKJames E. Kirby
James E. Kirby
TKTania Konry
Tania Konry

14 December 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
SSSaheli Sarkar
Saheli Sarkar
PSPooja Sabhachandani
Pooja Sabhachandani
RDRavi Dashnamoorthy
Ravi Dashnamoorthy
SPSayalee Potdar
Sayalee Potdar
SPSneha Purvey
Sneha Purvey
TKTania Konry
Tania Konry
Natural killer (NK) cells are phenotypically and functionally diverse lymphocytes that recognize and kill cancer cells. The susceptibility of target cancer cells to NK cell-mediated cytotoxicity depends on the strength and balance of regulatory (activating/inhibitory) ligands expressed on target cell surface. We performed gene expression arrays to determine patterns of NK cell ligands associated with B-cell non-Hodgkin lymphoma (b-NHL). Microarray analyses revealed significant upregulation of a multitude of NK-activating and costimulatory ligands across varied b-NHL cell lines and primary lymphoma cells, including ULBP1, CD72, CD48, and SLAMF6. To correlate genetic signatures with functional anti-lymphoma activity, we developed a dynamic and quantitative cytotoxicity assay in an integrated microfluidic droplet generation and docking array. Individual NK cells and target lymphoma cells were co-encapsulated in picoliter-volume droplets to facilitate monitoring of transient cellular interactions and NK cell effector outcomes at single-cell level. We identified significant variability in NK-lymphoma cell contact duration, frequency, and subsequent cytolysis. Death of lymphoma cells undergoing single contact with NK cells occurred faster than cells that made multiple short contacts. NK cells also killed target cells in droplets via contact-independent mechanisms that partially relied on calcium-dependent processes and perforin secretion, but not on cytokines (interferon-γ or tumor necrosis factor-α). We extended this technique to characterize functional heterogeneity in cytolysis of primary cells from b-NHL patients. Tumor cells from two diffuse large B-cell lymphoma patients showed similar contact durations with NK cells; primary Burkitt lymphoma cells made longer contacts and were lysed at later times. We also tested the cytotoxic efficacy of NK-92, a continuously growing NK cell line being investigated as an antitumor therapy, using our droplet-based bioassay. NK-92 cells were found to be more efficient in killing b-NHL cells compared with primary NK cells, requiring shorter contacts for faster killing activity. Taken together, our combined genetic and microfluidic analysis demonstrate b-NHL cell sensitivity to NK cell-based cytotoxicity, which was associated with significant heterogeneity in the dynamic interaction at single-cell level.

1 September 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
IFIlana Berger Fridman
Ilana Berger Fridman
JKJames Kostas
James Kostas
MGMichal Gregus
Michal Gregus
SRSomak Ray
Somak Ray
MSMatthew R. Sullivan
Matthew R. Sullivan
TKTania Konry
Tania Konry

17 October 2021 in Small
Verified
Journal Article
Open access
PDF file
RZRuoyu Zhong
Ruoyu Zhong
SYShujie Yang
Shujie Yang
GUGiovanni Stefano Ugolini
Giovanni Stefano Ugolini
TNTy Naquin
Ty Naquin
JZJinxin Zhang
Jinxin Zhang
Tony Jun HuangTony Jun Huang
Tony Jun Huang
Droplet microfluidics has revolutionized the biomedical and drug development fields by allowing for independent microenvironments to conduct drug screening at the single cell level. However, current microfluidic sorting devices suffer from drawbacks such as high voltage requirements (e.g., >200 Vpp), low biocompatibility, and/or low throughput. In this article, a single‐phase focused transducer (SPFT)‐based acoustofluidic chip is introduced, which outperforms many microfluidic droplet sorting devices through high energy transmission efficiency, high accuracy, and high biocompatibility. The SPFT‐based sorter can be driven with an input power lower than 20 Vpp and maintain a postsorting cell viability of 93.5%. The SPFT sorter can achieve a throughput over 1000 events per second and a sorting purity up to 99.2%. The SPFT sorter is utilized here for the screening of doxorubicin cytotoxicity on cancer and noncancer cells, proving its drug screening capability. Overall, the SPFT droplet sorting device shows great potential for fast, precise, and biocompatible drug screening.

18 July 2022 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
SASagar N. Agnihotri
Sagar N. Agnihotri
GUGiovanni Stefano Ugolini
Giovanni Stefano Ugolini
MSMatthew Ryan Sullivan
Matthew Ryan Sullivan
YYYichao Yang
Yichao Yang
AGAgustin De Ganzó
Agustin De Ganzó
TKTania Konry
Tania Konry
Unlike the common top-down approaches of single-cell analysis (investigating proteomics or genomics directly) which destroy the cell, this method preserves cell viability, allowing the same cell to be used for both genomics with functional assays.